The FDA has granted orphan drug designation (ODD) and RPDD to Arbor Biotechnologies' ABO-101, to treat primary hyperoxaluria ...
News Medical on MSN50m
New technology unlocks secrets of bacterial gene expressionHow do bacteria - harmless ones living in our bodies, or those that cause disease - organize their activities? A new study, combining powerful genomic-scale microscopy with a technical innovation, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback